T. Finney-Hayward

发表

Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage

A. Nicholson, R. Mayer, P. Barnes, 2008, Journal of Pharmacology and Experimental Therapeutics.

Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study.

S. Kugathasan, J. Kierkuś, Toshiaki Shimizu, 2021, The lancet. Gastroenterology & hepatology.

Different MAP-Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage

A. Nicholson, R. Mayer, L. Donnelly, 2007 .

Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages

A. Nicholson, P. Barnes, L. Donnelly, 2006, British journal of pharmacology.

Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis

J. Satsangi, A. Hart, G. D'Haens, 2022, United European gastroenterology journal.

Benefits of Structured Pediatric to Adult Transition in Inflammatory Bowel Disease

R. Russell, D. Gaya, S. McCartney, 2021, Journal of pediatric gastroenterology and nutrition.

Defective macrophage phagocytosis of bacteria in COPD

J. Wedzicha, P. Barnes, L. Donnelly, 2009, European Respiratory Journal.

Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1.

R. Panaccione, S. Danese, S. Schreiber, 2022, Gastroenterology & hepatology.

S773 Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies

S. Vermeire, Xiang Gao, E. Loftus, 2021, American Journal of Gastroenterology.

Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.

T. Hibi, G. D'Haens, M. Ferrante, 2022, Gastroenterology.

Structured Transition Enhances Clinical Outcome without an Increase in Healthcare Cost in Adolescent Patients with IBD: the UK Transit Study

R. Russell, D. Gaya, S. McCartney, 2017 .

Higher vs Standard Adalimumab Induction Dosing Regimens and 2 Maintenance Strategies: Randomized SERENE CD Trial Results.

S. Hanauer, G. D'Haens, M. Ferrante, 2022, Gastroenterology.

Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment.

M. Dubinsky, S. Vermeire, Xiang Gao, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Leukotriene B4 release by human lung macrophages via receptor- not voltage-operated Ca2+ channels

A. Nicholson, J. Westwick, P. Barnes, 2009, European Respiratory Journal.

A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index

A. Shields, C. Siegel, L. Peyrin-Biroulet, 2023, Journal of Crohn's & colitis.

Health Related Quality of Life (Hrqol) In Patients Who Have Undergone Colectomy for Ulcerative Colitis: Impacts of Complications Post-Surgery.

H. Doll, T. Finney-Hayward, B. Gentile, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: a Post Hoc Analysis of the Phase 3 Clinical Trial Programme.

T. Finney-Hayward, John Liu, C. Phillips, 2023, Journal of Crohn's & colitis.